How long does it take to see results from Wegovy?

The decision you're actually making: waiting for results vs. acting on incomplete information

If you're already taking Wegovy or considering it, the question of how long it takes to see results on Wegovy isn't purely academic. It shapes whether you stay the course through a slow first few weeks, whether you request a dose increase too soon, or whether you conclude too quickly that it isn't working. That decision is worth grounding in what the clinical evidence actually shows, rather than what you might read in a forum thread.

The honest picture: Wegovy works on a gradual titration schedule. Treatment starts at 0.25mg (a dose that exists mainly to let your system adjust, not to drive weight loss) and climbs, roughly every four weeks under your prescriber's guidance, toward the 2.4mg maintenance dose. Until you reach a therapeutic level, you may see relatively modest changes on the scale. That doesn't mean the medicine isn't working; it means the dose is still building. Patience at this stage is clinically reasonable, not just a platitude.

There is now also a 7.2mg maintenance dose, approved by the MHRA in April 2026 for adults with obesity, which produced around 20.7% average weight loss over 72 weeks in trials. Whether that higher dose is appropriate for you is a conversation for your prescriber, not a starting assumption.

What the trial data actually says about timing

The STEP 1 trial followed 1,961 adults with obesity over 68 weeks and found an average weight reduction of approximately 15% at the 2.4mg dose, compared with around 2.4% on placebo. Broken down across the timeline, weight loss accelerated through the titration period and continued through the maintenance phase, though the steepest gains came in the first 20 or so weeks once therapeutic doses were reached.

By around week 12 (when many participants were approaching or at 1mg) average losses were in the region of 5% of starting body weight. By week 28 most participants on the full maintenance dose were seeing 10% or more. These are averages; some people moved faster and some slower. The NHS patient information for semaglutide confirms that weight reduction is gradual and occurs alongside dietary and activity changes.

If you want to explore how individual factors affect that curve, our page on how long Wegovy takes to work covers the mechanism in more detail. For a broader look at results from Wegovy across different starting weights, that's a useful companion read too.

Three factors that genuinely shift the timeline

Starting weight matters more than most people expect. Somebody starting at a higher BMI may see a larger absolute number drop in the early months even if the percentage looks similar. Conversely, people closer to the lower eligibility threshold often see smaller absolute losses but similar percentage reductions.

Diet and activity are not optional extras. The clinical trials were conducted alongside a structured reduced-calorie programme. Wegovy reduces appetite reliably for most people; what you do with that reduced appetite (protein intake, hydration, keeping active) influences both speed and quality of results. A number of people find themselves making instinctive improvements once the appetite noise quietens, and that compounds quickly.

Dose tolerance is the third variable. Some people need longer at each step to manage GI side effects; others tolerate increases comfortably. Rushing titration to accelerate weight loss is counterproductive and clinically inappropriate. Your prescriber reviews progress before each increase, that process exists for good reason, not as a bureaucratic hurdle. If cost is part of your thinking as treatment goes on, our page on the cost of Wegovy in the UK gives an honest overview of what private treatment typically involves.

When to pause and speak to your prescriber

Two check-ins that matter: if you've been at the 2.4mg maintenance dose for six months and have lost less than 5% of your starting body weight, NICE guidance (TA875) recommends reviewing whether continuing is clinically appropriate. That's a clinical conversation, not a reason for alarm, but it is worth knowing in advance so the decision feels considered rather than abrupt.

Separately, side effects that feel severe or persistent (particularly stomach pain that reaches through to the back, which can occasionally signal pancreatitis) always warrant prompt medical attention rather than waiting for your next scheduled review. The MHRA publishes guidance on what to watch for; the Yellow Card scheme is where to report any suspected side effect you think deserves logging.

If you're weighing up whether Wegovy is the right treatment for your situation, the overview on our Wegovy treatment page covers eligibility, the titration schedule and what the clinical review at nume looks at. For questions about how semaglutide compares across different formulations, our page on how long semaglutide takes to show results is a related read. And if you'd like to understand the process before committing to anything, a look at our weight-loss treatment options page is a good starting point, no obligation, just the facts.

Results with Wegovy come gradually, as the medicine was designed to work. Most people find the pace easier to manage than they expected, particularly once the appetite change becomes familiar, like a dial turned down rather than a switch flipped. That adjustment usually happens earlier in the process than the scale shows it.